This inventor holds 1 USPTO granted patent. Top assignee: University of Kansas. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: The Innovations of Daniel R Thevenot
Introduction
Daniel R Thevenot is a notable inventor based in Paris, France. He is recognized for his contributions to the field of biomedical engineering, particularly in the development of implantable glucose sensors. His work has significant implications for diabetes management and monitoring.
Latest Patents
One of Thevenot's key patents is for an implantable glucose sensor. This invention involves implantable enzymatic sensors designed for biochemicals such as glucose. The sensors are characterized by their ideal size and geometry for long-term implantation, providing linear responses over relevant concentration ranges. The design includes an elongated body that supports an indicating electrode section with an appropriate enzyme immobilized to create an enzymatic indicating surface. A permeable synthetic polymer membrane is applied over the sensor body to protect the enzyme and regulate the diffusion of analyte, ensuring the linearity of sensor response. The flexible design of these sensors allows for implantation using a catheter, and one variant includes an internal indicating electrode body housed within an apertured, hollow needle for easy manipulation.
Career Highlights
Daniel R Thevenot is affiliated with the University of Kansas, where he continues to advance research in sensor technology. His innovative work has garnered attention in the scientific community, contributing to the development of more effective medical devices.
Collaborations
Thevenot has collaborated with notable colleagues such as Robert Sternberg and Brian S Hill. These partnerships have fostered advancements in research and development within the field of biomedical sensors.
Conclusion
Daniel R Thevenot's contributions to the field of implantable glucose sensors highlight his innovative spirit and dedication to improving healthcare technology. His work continues to influence the landscape of biomedical engineering and diabetes management.
